PrimeMD Inc
Other OTCTotal Valuation
PrimeMD Inc carries a market capitalization of 5,550.00, placing it among publicly traded companies globally.
| Market Cap | 5,550.00 |
| Enterprise Value | N/A |
Share Statistics
PrimeMD Inc currently has 3.07M shares outstanding.
| Shares Outstanding | 3.07M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 3.29, and the price-to-book ratio stands at -0.04.
| PE Ratio | N/A |
| PS Ratio | 3.29 |
| PB Ratio | -0.04 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | -16.89 |
| P/OCF Ratio | -16.89 |
Financial Position
PrimeMD Inc maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.20 |
| Quick Ratio | 1.20 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -16.50 |
| Return on Assets (ROA) | -5.92 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
PrimeMD Inc's stock has declined approximately -0.00000467% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -0.00000467% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, PrimeMD Inc generated 69,983.00 in revenue and converted that into -81,966.00 in net income, yielding earnings per share of -0.03. EBITDA reached -36,751.00, while operating income came in at -40,274.00.
| Revenue | 69,983.00 |
| Gross Profit | 10,473.00 |
| Operating Income | -40,274.00 |
| Pretax Income | N/A |
| Net Income | -81,966.00 |
| EBITDA | -36,751.00 |
| EBIT | -40,274.00 |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Total book value stands at -5.46M, with working capital of 72,303.00 providing operational flexibility.
| Cash & Cash Equivalents | 435,496.00 |
| Total Debt | N/A |
| Net Debt | -45,961.00 |
| Equity (Book Value) | -5.46M |
| Book Value Per Share | -1.78 |
| Working Capital | 72,303.00 |
Cash Flow
PrimeMD Inc produced -13,644.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -13,644.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -13,644.00 |
| FCF Per Share | 0.00 |
Margins
PrimeMD Inc operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -57.55 and net profit margin of -117.12 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -57.55 |
| Pretax Margin | N/A |
| Profit Margin | -117.12 |
| EBITDA Margin | -52.51 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | -5.92 |
Scores
PrimeMD Inc posts an Altman Z-Score of -4.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -4.64 |